Clincosm LogoSign in Get a demo

Non-Hodgkin's Lymphoma

Showing NaN - NaN of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (CG-806)

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Phoenix, Arizona
  • +30 more
Mar 28, 2022

Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma Trial in Canada, United States (ABT-263)

Completed
  • Chronic Lymphoid Leukemia
  • +5 more
  • Los Angeles, California
  • +11 more
Jul 28, 2021

Non-Hodgkin's Lymphoma Trial in United States (fludarabine and rituximab, fludarabine, rituximab, pixantrone)

Withdrawn
  • Non-Hodgkin's Lymphoma
  • fludarabine and rituximab
  • fludarabine, rituximab, pixantrone
  • Muscle Shoals, Alabama
  • +7 more
Oct 2, 2020

Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Tampa, Florida
  • +11 more
Sep 3, 2020

Non-Hodgkin's Lymphoma Trial in Worldwide (ibritumomab tiuxetan, BEAM chemo and autologous stem-cell transplantation)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • ibritumomab tiuxetan
  • BEAM chemotherapy and autologous stem-cell transplantation
  • Scottsdale, Arizona
  • +8 more
Aug 13, 2020

Non-Hodgkin's Lymphoma Trial in Royal Oak, Minneapolis, Rochester (LY317615)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Royal Oak, Michigan
  • +2 more
Jul 20, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +127 more
Jan 8, 2018

Non-Hodgkin's Lymphoma Trial in Omaha, New York, Rochester (bortezomib, bendamustine, rituximab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Omaha, Nebraska
  • +2 more
Jul 15, 2015

Non-Hodgkin's Lymphoma Trial in Worldwide (obinutuzumab (RO5072759), rituximab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Los angeles, California
  • +70 more
Aug 15, 2014

Non-Hodgkin's Lymphoma Trial in Australia, Canada, United States (bendamustine and rituximab)

Completed
  • Non-Hodgkin's Lymphoma
  • bendamustine and rituximab
  • Anchorage, Alaska
  • +33 more
May 8, 2014

Non-Hodgkin's Lymphoma Trial in Canada, Puerto Rico, United States (Bendamustine HCl)

Completed
  • Non-Hodgkin's Lymphoma
  • Bendamustine HCl
  • Birmingham, Alabama
  • +39 more
May 8, 2014

Non-Hodgkin's Lymphoma Trial in Canada, United States (SDX-105)

Completed
  • Non-Hodgkin's Lymphoma
  • Birmingham, Alabama
  • +16 more
May 8, 2014

Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Australia, Canada, United States (Bendamustine, Rituximab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +42 more
Apr 7, 2014

Non-Hodgkin's Lymphoma Trial in United States (IDEC-114)

Completed
  • Non-Hodgkin's Lymphoma
  • Birmingham, Alabama
  • +21 more
Sep 12, 2013

Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • VCL-CB01
  • Phosphate-buffered Saline (PBS)
  • Tucson, Arizona
  • +21 more
Jul 31, 2013

Non-Hodgkin's Lymphoma Trial in United States (IDEC-114)

Completed
  • Non-Hodgkin's Lymphoma
  • Tucson, Arizona
  • +3 more
Jun 7, 2012

Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Motexafin gadolinium)

Completed
  • Lymphoma
  • Non-Hodgkin's Lymphoma
  • Motexafin gadolinium
  • San Diego, California
  • +6 more
May 11, 2007

Non-Hodgkin's Lymphoma Trial in United States (Zevalin (ibritumomab tiuxetan), Rituxan (rituximab))

Terminated
  • Non-Hodgkin's Lymphoma
  • Zevalin (ibritumomab tiuxetan)
  • Rituxan (rituximab)
  • Huntsville, Alabama
  • +66 more
Sep 8, 2006